A comparative analysis of vascular stiffness indices and the results of blood test was carried out in 85 healthy donors aged 19-64 years, carriers of polymorphic variants of type 1 and type 2 melatonin receptor genes. The associations of polymorphic markers of type 1 MTNR1A (rs34532313) and type 2 MTNR1B (rs10830963) melatonin receptor genes with parameters of vascular stiffness and blood parameters in healthy patients were studied. Genoty** was performed using allele-specific PCR. In all patients, 24-h BP monitoring with assessment of arterial stiffness was performed. Allele C homozygotes of MTNR1A differed significantly from carriers of the major T allele by elevated triglyceride, LDL, and fibrinogen levels. The major allele C of the rs10830963 polymorphic variant of the MTNR1B gene is associated with elevated LDL and triglycerides, as well as with individual differences in the elastic properties of the vascular wall in the examined subjects.
Similar content being viewed by others
References
Brennan R, Jan JE, Lyons CJ. Light, dark, and melatonin: emerging evidence for the importance of melatonin in ocular physiology. Eye (Lond). 2007;21(7):901-908. doi: https://doi.org/10.1038/sj.eye.6702597
Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J. Pineal. Res. 2011;51(1):1-16. doi: https://doi.org/10.1111/j.1600-079X.2011.00916.x
Dubocovich ML. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med. 2007;(Suppl. 3):34-42. doi: https://doi.org/10.1016/j.sleep.2007.10.007
Gubin D, Weinert D, Solovieva SV, Durov AM, Litvinova NS, Danilova LA, Prokopiev NY, Trushnikov DY, Kartashova EA. Melatonin attenuates light-at-night effects on systolic blood pressure and body temperature but does not affect diastolic blood pressure and heart rate circadian rhythms. Biol. Rhythm Res. 2020;51(5):780-793. doi: https://doi.org/10.1080/09291016.2018.1564586
Reiter RJ, Tan DX, Korkmaz A, Erren TC, Piekarski C, Tamura H, Manchester LC. Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Crit. Rev. Oncog. 2007;13(4):303-328. doi: https://doi.org/10.1615/critrevoncog.v13.i4.30
Kvetnaia TV, Polyakova VO, Proshaev KI, Linkova NS, Sevostianova NN. Melatonin as a marker of ageing and age-associated diseases. Vestn. RUDN. Ser. Med. 2012;(S7):125-126. Russian.
Posokhov IN. Pulse wave velocity 24-hour monitoring with one-site measurements by oscillometry. Med. Devices (Auckl). 2013;6:11-15. doi: https://doi.org/10.2147/MDER.S42082
Efremov IS, Tukhvatullina DR, Efremova US, Gashkarimov VR, Tulbaeva NR, Akhmetova EA, Gizatullin TR. Association of alcohol withdrawal severity with MTNR1A(RS34532313) and MTNR1B(RS10830963) genes polymorphisms. Personalized Psychiatry and Neurology. 2021;1(2):111-116.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Ferrer-Hita J, Vargas M, Reiter RJ. Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction. Atherosclerosis. 2005;180(1):101-105. doi: https://doi.org/10.1016/j.atherosclerosis.2004.11.003
Popova PV, Klyushina AA, Vasilyeva LB, Tkachuk AS, Bolotko YA, Gerasimov AS, Pustozerov EA, Kravchuk EN, Predeus A, Kostareva AA, Grineva EN. Effect of gene-lifestyle interaction on gestational diabetes risk. Oncotarget. 2017;8(67):112 024-112 035. doi: https://doi.org/10.18632/oncotarget.22999
Arendt J. Melatonin and human rhythms. Chronobiol. Int. 2006;23(1-2):21-37. doi: https://doi.org/10.1080/07420520500464361
Montagnana M, Salvagno GL, Lippi G. Circadian variation within hemostasis: an underrecognized link between biology and disease? Semin. Thromb. Hemost. 2009;35(1):23-33. doi: https://doi.org/10.1055/s-0029-1214145
Wirtz PH, Spillmann M, Bärtschi C, Ehlert U, von Känel R. Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men. J. Pineal. Res. 2008;44(2):127-133. doi: https://doi.org/10.1111/j.1600-079X.2007.00499.x
Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R. Cardiovascular diseases: protective effects of melatonin. J. Pineal Res. 2008;44(1):16-25. doi: https://doi.org/10.1111/j.1600-079X.2007.00518.x
Gubin D, Neroev V, Malishevskaya T, Cornelissen G, Astakhov SY, Kolomeichuk S, Yuzhakova N, Kabitskaya Y, Weinert D. Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma. J. Pineal. Res. 2021;70(4):e12730. doi: https://doi.org/10.1111/jpi.12730
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 174, No. 10, pp. 468-471, October, 2022
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kolomeichuk, S.N., Korneva, V.A., Kuznetsova, T.Y. et al. MTNR1A and MTNR1B Gene Variants of the Melatonin Receptor and Arterial Stiffness in Persons without Arterial Hypertension. Bull Exp Biol Med 174, 460–463 (2023). https://doi.org/10.1007/s10517-023-05729-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05729-x